Rick E Winningham Insider Trading $TBPH Theravance Biopharma, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Rick E Winningham.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Rick E Winningham. Rick E Winningham is Chief Executive Officer in Innoviva, Inc. ($THRX) and Director in Jazz Pharmaceuticals plc ($JAZZ) and Director in OncoMed Pharmaceuticals Inc ($OMED) and Chief Executive Officer in Theravance Biopharma, Inc. ($TBPH).

Rick E Winningham in Theravance Biopharma, Inc.

Trading Symbol: TBPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Rick E Winningham: Chief Executive Officer
Holdings: 1,445,169 shares
Current Value: $44,222,171
Latest Transaction: Feb 10 2021
$TBPH Market Capitalization: $1.64B
$TBPH Previous Close: $30.60

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Rick E Winningham in Theravance Biopharma, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, THRX, JAZZ, OMED, TBPH

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 10 2021	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Grant	A	0.00	170,000	0	1,445,169	1.3 M to 1.4 M (+13.33 %)
Aug 24 2020	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Payment of Exercise	F	18.22	13,946	254,096	1,289,115	1.3 M to 1.3 M (-1.07 %)
May 22 2020	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Payment of Exercise	F	26.67	13,946	371,940	1,303,061	1.3 M to 1.3 M (-1.06 %)
Feb 24 2020	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Payment of Exercise	F	25.90	96,850	2,508,415	1,315,605	1.4 M to 1.3 M (-6.86 %)
Feb 05 2020	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Grant	A	0.00	168,000	0	1,412,455	1.2 M to 1.4 M (+13.50 %)
Feb 05 2020	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Grant	A	0.00	170,000	0	1,244,455	1.1 M to 1.2 M (+15.82 %)
Aug 22 2019	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Payment of Exercise	F	21.51	8,678	186,664	1,083,133	1.1 M to 1.1 M (-0.79 %)
May 22 2019	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Payment of Exercise	F	19.84	8,678	172,172	1,091,811	1.1 M to 1.1 M (-0.79 %)
Feb 22 2019	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Payment of Exercise	F	27.00	13,477	363,879	1,099,462	1.1 M to 1.1 M (-1.21 %)
Feb 07 2019	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Grant	A	0.00	147,000	0	1,112,939	965.9 K to 1.1 M (+15.22 %)
Feb 07 2019	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Grant	A	0.00	170,000	0	965,939	795.9 K to 965.9 K (+21.36 %)
Nov 21 2018	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Payment of Exercise	F	24.79	15,557	385,658	795,939	811.5 K to 795.9 K (-1.92 %)
Aug 22 2018	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Payment of Exercise	F	26.95	15,557	419,261	904,063	919.6 K to 904.1 K (-1.69 %)
May 22 2018	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Payment of Exercise	F	24.31	67,617	1,643,769	919,620	987.2 K to 919.6 K (-6.85 %)
May 16 2018	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Grant	A	0.00	105,000	0	987,237	882.2 K to 987.2 K (+11.90 %)
Feb 22 2018	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Payment of Exercise	F	29.09	13,005	378,315	881,372	894.4 K to 881.4 K (-1.45 %)
Feb 14 2018	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Grant	A	0.00	28,000	0	894,377	866.4 K to 894.4 K (+3.23 %)
Aug 11 2017	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Buy	P	24.50	10,000	245,000	866,377	856.4 K to 866.4 K (+1.17 %)
May 23 2017	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Payment of Exercise	F	36.83	15,460	569,392	856,377	871.8 K to 856.4 K (-1.77 %)
Feb 22 2017	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Payment of Exercise	F	33.78	33,264	1,123,658	870,135	903.4 K to 870.1 K (-3.68 %)
Feb 08 2017	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Grant	A	0.00	28,000	0	903,399	875.4 K to 903.4 K (+3.20 %)
Nov 22 2016	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Payment of Exercise	F	31.96	8,360	267,186	875,399	883.8 K to 875.4 K (-0.95 %)
Mar 17 2016	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Grant	A	0.00	280,000	0	882,056	602.1 K to 882.1 K (+46.51 %)
Aug 17 2015	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Buy	P	12.13	16,860	204,512	602,056	585.2 K to 602.1 K (+2.88 %)
Aug 17 2015	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Buy	P	11.79	63,140	744,421	583,298	520.2 K to 583.3 K (+12.14 %)
Feb 24 2015	TBPH	Theravance Biophar ...	Winningham Rick E	Chief Executive Off ...	Payment of Exercise	F	19.52	1,480	28,890	520,158	521.6 K to 520.2 K (-0.28 %)

Page: 1